Search Results for "Deep Vein Thrombosis Bcbstx Clinical Guidelines"
Original Source: Is deep vein thrombosis prophylaxis appropriate in the medical wards? A clinical pharmacists' intervention study.
Objective Venous thromboembolism is a major cause of mortality and morbidity in hospitalized patients. To evaluate physicians' approach to patients' thrombosis risk assessment and practice of thromboembolism prophylaxis in a teaching hospital, we designed an interventional prospective study. Setting This pre and post interventional study was conducted in the infectious diseases ward of Imam Khomeini referral hospital, Tehran, Iran. Method Patients' risk factors for thromboembolism during hospitalization cou...
Matching Channels
Deep venous thrombosis DVT prophylaxis
Venous Arterial Thromboembolism
Thrombosis is the formation of a blood clot inside a blood vessel, blocking a vein (venous thrombosis) or artery (arterial thrombosis). Venous Arterial Thromboembolism (VAT) is caused when some or a...
Matching News
NICE yes for Xarelto to treat blood clots
NICE is recommending Bayer’s Xarelto (rivaroxaban) for the treatment and prevention of deep vein thrombosis (DVT). The watchdog said in its final guidance that Xarelto is now an option for treating...
NICE now backs Xarelto to treat blood clots; negative on Bronchitol for CF
In final draft guidance published today (1 June 1), UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has recommended German drug major Bayer's (BAYN: DE) Xarelto (riv...
Treatment Algorithm Helps To Rule Out Deep Vein Thrombosis At The Primary Care Level
Algorithms improve certainty in ruling out deep and pelvic vein thrombosis at the primary level of patient care, say Lobna El Tabei and her co-authors in the current issue of the Deutsches Arzteblatt...
UK NICE says final "yes" for Bayer's Xarelto to treat blood clots
Confirming its final draft guidance last month (The Pharma Letter June 1), in final guidance published today (July 25), the UK drugs watchdog the National Institute for Health and Clinical Excellence...
Gene offers new insights into treatment strategies for deep-vein thrombosis
A gene associated with both protection against bacterial infection and excessive blood clotting could offer new insights into treatment strategies for deep-vein thrombosis -- the formation of a harmfu...
News From The Annals Of Internal Medicine: Jan. 15, 2013
1. Selective D-Dimer Testing for Suspected Deep Vein Thrombosis Safe and More Efficient than Testing Everyone D-dimer testing based on clinical pretest probability for deep vein thrombosis (DVT) is sa...
Incorrect Wording in Patient Page in: Air Travel–Related Deep Vein Thrombosis and Pulmonary Embolism
Incorrect Wording in Patient Page: In the Patient Page entitled “Air Travel–Related Deep Vein Thrombosis and Pulmonary Embolism” published in the December 19, 2012, issue of JAMA (2012;308[23]:2...
Matching PubMed Articles
Dalteparin in Critically Ill Patients.
To the Editor: The Prophylaxis for Thromboembolism in Critical Care Trial (PROTECT; ClinicalTrials.gov number, NCT00182143) investigators (April 7 issue)(1) report a significantly reduced incidence of...
Dalteparin in Critically Ill Patients.
To the Editor: The Prophylaxis for Thromboembolism in Critical Care Trial (PROTECT; ClinicalTrials.gov number, NCT00182143) investigators (April 7 issue)(1) report a significantly reduced incidence of...
Dalteparin in Critically Ill Patients.
To the Editor: The Prophylaxis for Thromboembolism in Critical Care Trial (PROTECT; ClinicalTrials.gov number, NCT00182143) investigators (April 7 issue)(1) report a significantly reduced incidence of...
Short versus extended thromboprophylaxis after total knee arthroplasty: A randomized comparison.
INTRODUCTION: The optimal duration of thromboprophylaxis after total knee arthroplasty remains uncertain. MATERIAL AND METHODS: We performed a randomized, open trial to determine whether to stop throm...
Thrombotic complications of pancreatic cancer: classical knowledge revisited.
This paper is an updated review of a classical clinical subject: the association between deep vein thrombosis and pancreatic cancer. Recent epidemiological data support the empirical observation of Tr...
